InsidersTradesSigma
Follow the Botanix Pharmaceuticals Ltd stock price and the full management transaction log of the company, a listed equity based in Australia. Shares are quoted on the AU market, under the supervision of ASX. Operating in the Health Care sector, Botanix Pharmaceuticals Ltd has published 2 public disclosures. Market capitalisation: €54.7m. The latest transaction was reported on 31 August 2026 (Sale). Among the most active insiders: Dr Patricia Walker. Every trade is openly available.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
2 of 2 declarations
Botanix Pharmaceuticals Ltd is a company focused on developing cannabinoid-based treatments for dermatological conditions and other diseases. It is listed on the XASX market.